抗体识别简介辅助的Hapten设计,以调节抗体生成,并预期用于免疫试验开发的性能
Peipei Li1, Weilin Wu1, Yuan Li2
1National Key Laboratory of Veterinary Public Health Safety, Beijing Key Laboratory of Detection Technology for Animal-Derived Food Safety, College of Veterinary Medicine China Agricultural University, 100193 Beijing, People' s Republic of China.
Analytical chemistry
|December 5, 2024
概括
一个新的触子设计策略 (ARPHD) 改善了检测烯 (FF) 和烯胺 (FFA) 的抗体生成. 这种方法可以在食物和水中同时检测,达到前所未有的灵敏度.
科学领域:
- 免疫化学 免疫化学
- 分析化学 分析化学
- 生物技术是生物技术.
背景情况:
- 对于抗体生成的传统的哈普顿设计往往忽视了抗体识别配置文件,导致性能不佳,特别是对于广特异性抗体.
- 开发抗体的小分子,如烯 (FF) 和烯胺 (FFA) 需要小心翼翼的 hapten 设计,以确保所需的特异性和亲和力.
研究的目的:
- 提出和验证一种新的策略,即抗体识别配置辅助的子设计 (ARPHD),用于合理的子设计.
- 提高FF和FFA检测的抗体生成,以提高性能和广泛的特异性.
- 开发一种敏感的方法,用于在复杂矩阵中同时检测FF和FFA.
主要方法:
- 使用FF和FFA作为模型分析物的未覆盖的抗体识别档案.
- 基于ARPHD原则设计的新型子,包含,并省略不良部分.
- 运用计算化学和动物免疫来识别和产生抗体.
- 开发了一种间接竞争性的ELISA (icELISA) 用于同时检测.
主要成果:
- 鉴定出能促进FFA的抗体生成,而-COCHCl2部分对广泛特异性抗体不利.
- 通过使用ARPHD设计的哈普成功生成了对FF和FFA的抗体,其IC50值为3.09和3.75 ng mL−1.
- 在河水和食品样本中建立了一个 icELISA,用于同时检测FF和FFA,其 LOD为2.2414.6 μg kg-1.1.
结论:
- 该ARPHD策略理性地指导 hapten 设计,导致抗体具有更好的性能和广泛的特异性.
- 抗体的光链在差异识别中起着至关重要的作用.
- ARPHD是一个多功能平台,可扩展到其他化学化合物,用于开发敏感的免疫试验.
相关概念视频
Affinity and Avidity
35.8K
Overview
35.8K
Immunoprecipitation
5.3K
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
5.3K
Hybridoma Technology
14.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K


